Acorah Software Products - Accounts Production 19.2.450 false true 31 October 2024 1 November 2023 false 1 November 2024 31 October 2025 31 October 2025 09832452 Dr C J Buchanan iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09832452 2024-10-31 09832452 2025-10-31 09832452 2024-11-01 2025-10-31 09832452 frs-core:CurrentFinancialInstruments 2025-10-31 09832452 frs-core:ComputerEquipment 2025-10-31 09832452 frs-core:ComputerEquipment 2024-11-01 2025-10-31 09832452 frs-core:ComputerEquipment 2024-10-31 09832452 frs-core:FurnitureFittings 2025-10-31 09832452 frs-core:FurnitureFittings 2024-11-01 2025-10-31 09832452 frs-core:FurnitureFittings 2024-10-31 09832452 frs-core:ShareCapital 2025-10-31 09832452 frs-core:RetainedEarningsAccumulatedLosses 2025-10-31 09832452 frs-bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 09832452 frs-bus:FilletedAccounts 2024-11-01 2025-10-31 09832452 frs-bus:SmallEntities 2024-11-01 2025-10-31 09832452 frs-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 09832452 frs-bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 09832452 frs-bus:OrdinaryShareClass1 2024-11-01 2025-10-31 09832452 frs-bus:OrdinaryShareClass1 2025-10-31 09832452 frs-bus:OrdinaryShareClass2 2024-11-01 2025-10-31 09832452 frs-bus:OrdinaryShareClass2 2025-10-31 09832452 frs-bus:Director1 2024-11-01 2025-10-31 09832452 frs-countries:EnglandWales 2024-11-01 2025-10-31 09832452 2023-10-31 09832452 2024-10-31 09832452 2023-11-01 2024-10-31 09832452 frs-core:CurrentFinancialInstruments 2024-10-31 09832452 frs-core:ShareCapital 2024-10-31 09832452 frs-core:RetainedEarningsAccumulatedLosses 2024-10-31 09832452 frs-bus:OrdinaryShareClass1 2023-11-01 2024-10-31 09832452 frs-bus:OrdinaryShareClass2 2023-11-01 2024-10-31
Registered number: 09832452
Sadler Scientific Ltd
Unaudited Financial Statements
For The Year Ended 31 October 2025
Sadler Scientific Ltd
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—5

Page 1
Sadler Scientific Ltd
Balance Sheet
As At 31 October 2025
Balance Sheet
Registered number: 09832452

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 4 |  | 1,284 |  | 2,568
|  |  | 1,284 |  | 2,568
CURRENT ASSETS
Debtors | 5 | 165,753 |  | 8,314 |
Cash at bank and in hand |  | 184,119 |  | 266,911 |
|  | 349,872 |  | 275,225 |
Creditors: Amounts Falling Due Within One Year | 6 | (67,154 ) |  | (38,703 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 282,718 |  | 236,522
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 284,002 |  | 239,090
PROVISIONS FOR LIABILITIES
Deferred Taxation |  |  | (321 ) |  | (642 )
NET ASSETS |  |  | 283,681 |  | 238,448
CAPITAL AND RESERVES
Called up share capital | 7 |  | 3 |  | 3
Profit and Loss Account |  |  | 283,678 |  | 238,445
SHAREHOLDERS' FUNDS |  |  | 283,681 |  | 238,448

Page 1
Page 2
Sadler Scientific Ltd
Balance Sheet (continued)
As At 31 October 2025
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Dr C J Buchanan Director
8 June 2026

The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Sadler Scientific Ltd
Notes to the Financial Statements
For The Year Ended 31 October 2025
Notes to the Financial Statements
1. General Information
Sadler Scientific Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 09832452 . The registered office is 45 Elm Drive, Holmes Chapel, Crewe, CW4 7QA.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of section 1a "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £.
The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable net of VAT and trade discounts. The policies have been consistently applied to all years presented unless otherwise stated.
Rendering of services
When the outcome of a transaction can be estimated reliably, turnover from medical research is recognised by reference to the stage of completion at the balance sheet date. Stage of completion is measured be reference to the date in which the service was provided.
Where the outcome cannot be measured reliably, turnover is recognised only to the extent of the expenses recognised that are recoverable.
Interest receivable
Interest income is recognised using the effective interest method.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are stated at cost less accumulated depreciation. Cost includes costs directly attributable to making the asset capable of operating as intended. Depreciation is provided at the following rates in order to write off each asset over its estimated useful life.

Fixtures & Fittings | 20% on cost
Computer Equipment | 33.3% on cost

2.4. Foreign Currencies
Foreign currency transactions are initially recognised by applying to the foreign currency amount the spot exchange rate between the functional currency and the foreign currency at the date of the transaction.
Monetary assets and liabilities denominated in a foreign currency at the balance sheet date are translated using the closing rate.
2.5. Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current or deferred taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.
...CONTINUED
Page 3
Page 4
Sadler Scientific Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 October 2025
2.5. Taxation - continued
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
2.6. Pensions
The company operates a defined contribution pension scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
2.7. Debtors and creditors receivable / payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
4. Tangible Assets

| Fixtures & Fittings | Computer Equipment | Total
--- | --- | --- | ---
| £ | £ | £
Cost
As at 1 November 2024 | 9,912 | 4,487 | 14,399
As at 31 October 2025 | 9,912 | 4,487 | 14,399
Depreciation
As at 1 November 2024 | 9,912 | 1,919 | 11,831
Provided during the period | - | 1,284 | 1,284
As at 31 October 2025 | 9,912 | 3,203 | 13,115
Net Book Value
As at 31 October 2025 | - | 1,284 | 1,284
As at 1 November 2024 | - | 2,568 | 2,568

5. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Trade debtors | 33,556 |  | 6,422
Prepayments and accrued income | 2,096 |  | 1,892
Other debtors | 130,101 |  | -
| 165,753 |  | 8,314

Page 4
Page 5
Sadler Scientific Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 October 2025
6. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Corporation tax | 52,988 |  | 27,475
VAT | 13,315 |  | 5,525
Other creditors | - |  | 2,081
Accruals and deferred income | 241 |  | 1,912
Director's loan account | 610 |  | 1,710
| 67,154 |  | 38,703

7. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
Allotted, called up and fully paid | £ |  | £
2 Ordinary Shares of £ 1.00 each | 2 |  | 2
1 Ordinary A shares of £ 1.00 each | 1 |  | 1
| 3 |  | 3

Page 5